CASE-HISTORY - PHARMACEUTICAL WASTE-WATER TREATMENT-PLANT UPGRADE, SMITHKLINE-BEECHAM-PHARMACEUTICALS-COMPANY

被引：10

作者：

GARCIA, A

RIVAS, HM

FIGUEROA, JL

MONROE, AL

机构：

[1] OLVER INC,CONSULTING ENGINEERS & ENVIRONM LABS,BLACKSBURG,VA 24060

[2] UNIPRO ARCHITECTS & ENGINEERS,SAN JUAN,PR

[3] SMITHKLINE BEECHAM PHARMACEUT,CIDRA,PR

来源：

DESALINATION | 1995年 / 102卷 / 1-3期

关键词：

D O I：

10.1016/0011-9164(95)00061-6

中图分类号：

TQ [化学工业];

学科分类号：

0817 ;

摘要：

Olver Incorporated and UNIPRO (OU) were retained by SmithKline Beecham Pharmaceuticals Company (SB) to evaluate effluent discharge limits proposed by the Puerto Rico Environmental Quality Board (EQB) and determine the most cost effective treatment alternative that would allow the wastewater treatment plant to meet proposed discharge limits. Further, OU was directed to recommend the most cost effective treatment alternative and summarize their findings in a preliminary engineering report on November 9, 1990. Following completion of the engineering evaluations and treatability studies conducted by SE staff, a final process flow diagram (PFD) (see Fig. 1) was selected by SB. The selected alternative is currently being implemented by SB.

引用

页码：255 / 263

页数：9